EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Non‐invasive risk stratification of congenital cytomegalovirus infection using extracellular vesicle biomarkers

Lierni Ugartemendia, Brenna L. Hughes, Robert Suchting, Menna Elsaka, Gail J. Demmler‐Harrison, Laura Goetzl

Pregnancy · 2026-11 · 2 (6)

DOI: 10.1002/pmf2.70495 ↗

At a glance

Journal article in Pregnancy, published online on 2026-11-16. Written by Lierni Ugartemendia and 5 co-authors. 45 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Institute of Child Health and Human Development, National Center for Advancing Translational Sciences, National Institutes of Health.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Introduction

Cytomegalovirus (CMV) is one of the most common infections during pregnancy and can result in congenital CMV (cCMV) infection and long‐term sequelae. In utero diagnosis of cCMV requires amniocentesis. In this nested case–control study, we investigated the use of fetal neuronally derived extracellular vesicles (fNEVs) in maternal circulation to characterize fetal brain alterations following primary maternal infection and evaluate their association with cCMV infection and disease severity.

Methods

We used stored plasma samples from women enrolled in a multicenter randomized trial of CMV hyperimmune globulin (CMV‐HIG) ( n = 98). We isolated fNEVs from maternal plasma prior to treatment randomization (Gestational age: 20.04 ± 4.2 weeks) and 8 weeks later, and measured EV biomarkers of neuronal injury/injury response: synaptopodin (SYNPO) and Bcl‐2‐associated factor 1 (BCLAF1), both normalized to the EV marker CD81. We assessed the associations of these biomarkers with neonatal infection or symptomatic status using generalized linear mixed models and predictive performance analysis.

Results

Fetal CMV infection was associated with higher pre‐randomization levels of fNEV SYNPO ( p = 0.001) and BCLAF1 ( p = 0.040). BCLAF1 levels were also higher in symptomatic subjects ( p = 0.029) pre‐randomization. The combined SYNPO/BCLAF1 model demonstrated modest discrimination for fetal infection (area under the curve [AUC] = 0.713; 95% confidence interval [CI] = [0.612, 0.815]). We observed a decrease in SYNPO levels over time in symptomatic cCMV ( p = 0.006). In symptomatic subjects those exposed to CMV‐HIG had higher SYNPO levels than the placebo group ( p = 0.004). Commonly, acute injury is associated with decreased levels of SYNPO, while increased SYNPO suggests a chronic response/repair state. Taken together, our findings suggest that noninvasive risk‐stratification of CMV infection/symptomatic infection may be possible with testing refinement.

Funding

  • National Institute of Child Health and Human Development
  • National Center for Advancing Translational Sciences
  • National Institutes of Health

Cite

APA

Ugartemendia, L., Hughes, B. L., Suchting, R., Elsaka, M., Demmler‐Harrison, G. J., & Goetzl, L. (2026). Non‐invasive risk stratification of congenital cytomegalovirus infection using extracellular vesicle biomarkers. Pregnancy, 2(6). https://doi.org/10.1002/pmf2.70495

Vancouver

Ugartemendia L, Hughes BL, Suchting R, Elsaka M, Demmler‐Harrison GJ, Goetzl L. Non‐invasive risk stratification of congenital cytomegalovirus infection using extracellular vesicle biomarkers. Pregnancy. 2026;2(6). doi:10.1002/pmf2.70495

BibTeX
@article{Ugartemendia2026,
  author = {Ugartemendia, Lierni and Hughes, Brenna L. and Suchting, Robert and Elsaka, Menna and Demmler‐Harrison, Gail J. and Goetzl, Laura},
  title = {Non‐invasive risk stratification of congenital cytomegalovirus infection using extracellular vesicle biomarkers},
  journal = {Pregnancy},
  year = {2026},
  volume = {2},
  number = {6},
  doi = {10.1002/pmf2.70495}
}
Start for free →